位置:首页 > 蛋白库 > DGKG_MOUSE
DGKG_MOUSE
ID   DGKG_MOUSE              Reviewed;         788 AA.
AC   Q91WG7;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   03-AUG-2022, entry version 163.
DE   RecName: Full=Diacylglycerol kinase gamma;
DE            Short=DAG kinase gamma;
DE            EC=2.7.1.107 {ECO:0000269|PubMed:32033984};
DE   AltName: Full=88 kDa diacylglycerol kinase;
DE   AltName: Full=Diglyceride kinase gamma;
DE            Short=DGK-gamma;
GN   Name=Dgkg; Synonyms=Dagk3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, DISRUPTION PHENOTYPE, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=32033984; DOI=10.1523/eneuro.0319-19.2020;
RA   Tsumagari R., Kakizawa S., Kikunaga S., Fujihara Y., Ueda S., Yamanoue M.,
RA   Saito N., Ikawa M., Shirai Y.;
RT   "DGKgamma Knock-Out Mice Show Impairments in Cerebellar Motor Coordination,
RT   LTD, and the Dendritic Development of Purkinje Cells through the Activation
RT   of PKCgamma.";
RL   ENeuro 7:0-0(2020).
CC   -!- FUNCTION: Diacylglycerol kinase that converts diacylglycerol/DAG into
CC       phosphatidic acid/phosphatidate/PA and regulates the respective levels
CC       of these two bioactive lipids (PubMed:32033984). Thereby, acts as a
CC       central switch between the signaling pathways activated by these second
CC       messengers with different cellular targets and opposite effects in
CC       numerous biological processes (PubMed:32033984). Has no apparent
CC       specificity with regard to the acyl compositions of diacylglycerol (By
CC       similarity). Specifically expressed in the cerebellum where it controls
CC       the level of diacylglycerol which in turn regulates the activity of
CC       protein kinase C gamma (PubMed:32033984). Through protein kinase C
CC       gamma, indirectly regulates the dendritic development of Purkinje
CC       cells, cerebellar long term depression and ultimately cerebellar motor
CC       coordination (PubMed:32033984). {ECO:0000250|UniProtKB:P49619,
CC       ECO:0000269|PubMed:32033984}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycerol + ATP = a 1,2-diacyl-sn-glycero-3-
CC         phosphate + ADP + H(+); Xref=Rhea:RHEA:10272, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17815, ChEBI:CHEBI:30616, ChEBI:CHEBI:58608,
CC         ChEBI:CHEBI:456216; EC=2.7.1.107;
CC         Evidence={ECO:0000269|PubMed:32033984};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10273;
CC         Evidence={ECO:0000269|PubMed:32033984};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-didecanoyl-sn-glycerol + ATP = 1,2-didecanoyl-sn-glycero-
CC         3-phosphate + ADP + H(+); Xref=Rhea:RHEA:43428, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:18155, ChEBI:CHEBI:30616, ChEBI:CHEBI:78227,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:P49620};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43429;
CC         Evidence={ECO:0000250|UniProtKB:P49620};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycerol + ATP = 1,2-di-(9Z-
CC         octadecenoyl)-sn-glycero-3-phosphate + ADP + H(+);
CC         Xref=Rhea:RHEA:40327, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:52333, ChEBI:CHEBI:74546, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:P49620};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40328;
CC         Evidence={ECO:0000250|UniProtKB:P49620};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(9Z,12Z)-octadecadienoyl-sn-glycerol + ATP =
CC         1-octadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphate +
CC         ADP + H(+); Xref=Rhea:RHEA:40339, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:77097, ChEBI:CHEBI:77098,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:P49620};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40340;
CC         Evidence={ECO:0000250|UniProtKB:P49620};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol
CC         + ATP = 1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-
CC         3-phosphate + ADP + H(+); Xref=Rhea:RHEA:40323, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:75728, ChEBI:CHEBI:77091,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:P49620};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:40324;
CC         Evidence={ECO:0000250|UniProtKB:P49620};
CC   -!- ACTIVITY REGULATION: The activity is calcium-dependent (By similarity).
CC       Requires phosphatidylserine for maximal activity (By similarity).
CC       {ECO:0000250|UniProtKB:P49619, ECO:0000250|UniProtKB:P49620}.
CC   -!- PATHWAY: Lipid metabolism; glycerolipid metabolism.
CC       {ECO:0000269|PubMed:32033984}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:P49620}.
CC       Cytoplasm, cytosol {ECO:0000250|UniProtKB:P49619}. Cytoplasm,
CC       cytoskeleton {ECO:0000250|UniProtKB:P49620}.
CC   -!- TISSUE SPECIFICITY: Expressed in hippocampus and cerebellar Purkinje
CC       cells and weakly and diffusely expressed in the granule cells.
CC       {ECO:0000269|PubMed:32033984}.
CC   -!- DISRUPTION PHENOTYPE: Homozygous knockout mice show impairments in
CC       motor coordination, long-term depression/LTD and development of
CC       Purkinje cells (PubMed:32033984). The level of phosphatidic acid in
CC       synaptosomal membranes is significantly decreased (PubMed:32033984).
CC       The number of branches, the total length of the dendrites and the
CC       membrane capacitance of the distal dendritic region are significantly
CC       lower (PubMed:32033984). {ECO:0000269|PubMed:32033984}.
CC   -!- SIMILARITY: Belongs to the eukaryotic diacylglycerol kinase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC015278; AAH15278.1; -; mRNA.
DR   CCDS; CCDS28068.1; -.
DR   RefSeq; NP_619591.1; NM_138650.2.
DR   AlphaFoldDB; Q91WG7; -.
DR   IntAct; Q91WG7; 1.
DR   MINT; Q91WG7; -.
DR   STRING; 10090.ENSMUSP00000087371; -.
DR   iPTMnet; Q91WG7; -.
DR   PhosphoSitePlus; Q91WG7; -.
DR   EPD; Q91WG7; -.
DR   MaxQB; Q91WG7; -.
DR   PaxDb; Q91WG7; -.
DR   PRIDE; Q91WG7; -.
DR   ProteomicsDB; 277325; -.
DR   Antibodypedia; 34852; 126 antibodies from 18 providers.
DR   DNASU; 110197; -.
DR   Ensembl; ENSMUST00000089925; ENSMUSP00000087371; ENSMUSG00000022861.
DR   GeneID; 110197; -.
DR   KEGG; mmu:110197; -.
DR   UCSC; uc007ysg.2; mouse.
DR   CTD; 1608; -.
DR   MGI; MGI:105060; Dgkg.
DR   VEuPathDB; HostDB:ENSMUSG00000022861; -.
DR   eggNOG; KOG1169; Eukaryota.
DR   GeneTree; ENSGT00940000156768; -.
DR   InParanoid; Q91WG7; -.
DR   OMA; ALCKYTV; -.
DR   OrthoDB; 633642at2759; -.
DR   PhylomeDB; Q91WG7; -.
DR   TreeFam; TF313104; -.
DR   Reactome; R-MMU-114508; Effects of PIP2 hydrolysis.
DR   UniPathway; UPA00230; -.
DR   BioGRID-ORCS; 110197; 2 hits in 73 CRISPR screens.
DR   ChiTaRS; Dgkg; mouse.
DR   PRO; PR:Q91WG7; -.
DR   Proteomes; UP000000589; Chromosome 16.
DR   RNAct; Q91WG7; protein.
DR   Bgee; ENSMUSG00000022861; Expressed in subiculum and 109 other tissues.
DR   ExpressionAtlas; Q91WG7; baseline and differential.
DR   Genevisible; Q91WG7; MM.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0004143; F:diacylglycerol kinase activity; IMP:UniProtKB.
DR   GO; GO:0008289; F:lipid binding; ISO:MGI.
DR   GO; GO:0003951; F:NAD+ kinase activity; IEA:InterPro.
DR   GO; GO:0046339; P:diacylglycerol metabolic process; IMP:UniProtKB.
DR   GO; GO:0046486; P:glycerolipid metabolic process; ISO:MGI.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0046834; P:lipid phosphorylation; IMP:UniProtKB.
DR   GO; GO:0090038; P:negative regulation of protein kinase C signaling; IMP:UniProtKB.
DR   GO; GO:0048666; P:neuron development; IEA:Ensembl.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0007205; P:protein kinase C-activating G protein-coupled receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0050773; P:regulation of dendrite development; IMP:UniProtKB.
DR   CDD; cd00029; C1; 1.
DR   CDD; cd00051; EFh; 1.
DR   Gene3D; 1.10.238.110; -; 2.
DR   Gene3D; 3.40.50.10330; -; 1.
DR   InterPro; IPR017438; ATP-NAD_kinase_N.
DR   InterPro; IPR046349; C1-like_sf.
DR   InterPro; IPR029477; DAG_kinase_typeI_N.
DR   InterPro; IPR037607; DGK.
DR   InterPro; IPR038199; DGK_typeI_N_sf.
DR   InterPro; IPR000756; Diacylglycerol_kin_accessory.
DR   InterPro; IPR001206; Diacylglycerol_kinase_cat_dom.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR016064; NAD/diacylglycerol_kinase_sf.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   PANTHER; PTHR11255; PTHR11255; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF14513; DAG_kinase_N; 1.
DR   Pfam; PF00609; DAGK_acc; 1.
DR   Pfam; PF00781; DAGK_cat; 1.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00045; DAGKa; 1.
DR   SMART; SM00046; DAGKc; 1.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF111331; SSF111331; 1.
DR   SUPFAM; SSF47473; SSF47473; 2.
DR   SUPFAM; SSF57889; SSF57889; 2.
DR   PROSITE; PS50146; DAGK; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   ATP-binding; Calcium; Cytoplasm; Cytoskeleton; Kinase; Lipid metabolism;
KW   Membrane; Metal-binding; Nucleotide-binding; Reference proteome; Repeat;
KW   Transferase; Zinc; Zinc-finger.
FT   CHAIN           1..788
FT                   /note="Diacylglycerol kinase gamma"
FT                   /id="PRO_0000218460"
FT   DOMAIN          172..207
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          217..252
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          427..561
FT                   /note="DAGKc"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00783"
FT   ZN_FING         268..318
FT                   /note="Phorbol-ester/DAG-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   ZN_FING         333..380
FT                   /note="Phorbol-ester/DAG-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00226"
FT   REGION          83..149
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          765..788
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        94..108
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         185
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         187
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         189
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         196
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         230
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         232
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         234
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         241
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
SQ   SEQUENCE   788 AA;  88523 MW;  969298DFD144F5DF CRC64;
     MSEEQWVSLS SEEFDQLQKY SEYSSKKIKD VLAEFNEGGS LRQYDPHKPI SYDVFKLFMR
     AYLEVDLPQP LSTHLFLAFS QKPRQETPDH PKEGASSSEP NVSDYNSDNA AKADEACAPD
     TESKTTKTQA PSKELEAAAP WEDPGALASS SDAPVVYLKD VVCYLSLMET GRPQDKLEFM
     FRLYDSDENG LLDQAEMDQI VSQMLHVAQY LEWDPTELRP ILKEMLQGMD YDKDGFVSLQ
     EWINGGMTTI PLLVLLGMDD SGSKGDGRHA WTLKHFKKPT YCNFCRAMLM GVGKQGLCCI
     YCKYTVHQRC VSKTIHGCVK TNSKAKRSGE VMQHAWVEGN SSVKCDRCHK SIKCYQSVTA
     RHCVWCRMTF HRKCELSTVC DGGELKDHIL LPTSICPVSG DRQGGKSDGS VAAKGELVTQ
     YKIIPSPGTH PLLVLVNPKS GGRQGERILR KFHYLLNPEQ VFNLDNGGPT PGLNFFHDTP
     DFRVLACGGD GTVGWILDCI DKANFTKHPP VAVLPLGTGN DLARCLRWGG GYEGGSLTKI
     LKEIEQSPLV MLDRWYLEVM PREEVENGDQ VPYNIMNNYF SIGVDASIAH RFHMMREKHP
     EKFNSRMKNK LWYFEFGTSE TFAATCKKLH DHIELECDGV EVDLSNIFLE GIAILNIPSM
     YGGTNLWGET KKNRAVIRES RKSVTDPKEL KCCVQDLSDQ LLEVVGLEGA MEMGQIYTGL
     KSAGRRLAQC SSVTIRTNKL LPMQVDGEPW MQPQCTIKIT HKNQAPMMMG PPQKSSFFSL
     RRKSRSKD
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024